DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
SUPTAVUMAB
3
Antibody
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Fusion glycoprotein F0 inhibitor
SUPTAVUMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
A0ZE931055
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEPPERMINT OIL
3
Small molecule
Investigational
Unknown
Unknown
Abdominal Pain; Cystitis, Interstitial
Unknown
PEPPERMINT OIL
×
Maximum Phase:
3
First Approval:
None
UNII:
AV092KU4JH
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CB-5945
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CB-5945
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SUCCINIC ACID
3
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies
Unknown
SUCCINIC ACID
×
Maximum Phase:
3
First Approval:
None
UNII:
AB6MNQ6J6L
Molecule Type:
Small molecule
Molecular Formula:
C4H6O4
Molecular Weight:
118.09
AlogP:
-0.06
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MEASLES VIRUS VACCINE LIVE
3
Unknown
Investigational
Unknown
Unknown
Measles; Meningococcal Infections
Unknown
MEASLES VIRUS VACCINE LIVE
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IDALOPIRDINE
3
Small molecule
Investigational
Unknown
Unknown
Schizophrenia; Alzheimer Disease
Serotonin 6 (5-HT6) receptor antagonist
IDALOPIRDINE
×
Maximum Phase:
3
First Approval:
None
UNII:
59WCJ0YNWM
Molecule Type:
Small molecule
Molecular Formula:
C20H19F5N2O
Molecular Weight:
398.38
AlogP:
4.92
PSA:
37.05
HBD:
2.0
HBA:
#RotB:
9.0
Source:
AVORALSTAT
3
Small molecule
Investigational
Unknown
Unknown
Angioedemas, Hereditary
Plasma kallikrein inhibitor
AVORALSTAT
×
Maximum Phase:
3
First Approval:
None
UNII:
UX17773O15
Molecule Type:
Small molecule
Molecular Formula:
C28H27N5O5
Molecular Weight:
513.55
AlogP:
3.77
PSA:
167.49
HBD:
5.0
HBA:
#RotB:
10.0
Source:
INIPARIB
3
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Retroviridae Infections; Breast Neoplasms; Carcinoma, Squamous Cell; Neoplasms
Reactive nitro radical
INIPARIB
×
Maximum Phase:
3
First Approval:
None
UNII:
2ZWI7KHK8F
Molecule Type:
Small molecule
Molecular Formula:
C7H5IN2O3
Molecular Weight:
292.03
AlogP:
1.3
PSA:
86.23
HBD:
1.0
HBA:
#RotB:
2.0
Source:
MIDOMAFETAMINE
3
Small molecule
Investigational
Unknown
Unknown
Child Development Disorders, Pervasive; Alcoholism; Amphetamine-Related Disorders; Liver Diseases; Substance-Related Disorders; Anorexia Nervosa; Anxiety; Stress Disorders, Post-Traumatic
Unknown
MIDOMAFETAMINE
×
Maximum Phase:
3
First Approval:
None
UNII:
KE1SEN21RM
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO2
Molecular Weight:
193.25
AlogP:
1.57
PSA:
30.49
HBD:
1.0
HBA:
#RotB:
3.0
Source:
RELAMORELIN
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Ghrelin receptor agonist
RELAMORELIN
×
Maximum Phase:
3
First Approval:
None
UNII:
BIW199E18V
Molecule Type:
Small molecule
Molecular Formula:
C43H50N8O5S
Molecular Weight:
790.99
AlogP:
2.59
PSA:
199.34
HBD:
8.0
HBA:
#RotB:
15.0
Source:
ALG-991
3
Antibody
Investigational
Unknown
Unknown
Unknown
Urushiol inhibitor
ALG-991
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FAROPENEM
3
Small molecule
Investigational
Unknown
Unknown
Tuberculosis; Tuberculosis, Pulmonary; Bacterial Infections; Pneumonia
Bacterial penicillin-binding protein inhibitor
FAROPENEM
×
Maximum Phase:
3
First Approval:
None
UNII:
F52Y83BGH3
Molecule Type:
Small molecule
Molecular Formula:
C12H15NO5S
Molecular Weight:
285.32
AlogP:
0.37
PSA:
87.07
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ZUCAPSAICIN
3
Small molecule
Investigational
Unknown
Unknown
Dry Eye Syndromes; Neuralgia, Postherpetic; Arthralgia; Myalgia; Osteoarthritis, Knee; Pain
Vanilloid receptor agonist
ZUCAPSAICIN
×
Maximum Phase:
3
First Approval:
None
UNII:
15OX67P384
Molecule Type:
Small molecule
Molecular Formula:
C18H27NO3
Molecular Weight:
305.42
AlogP:
3.79
PSA:
58.56
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ZUTECTRA
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ZUTECTRA
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGNIVACOGIN
3
Oligonucleotide
Investigational
Unknown
Unknown
Acute Coronary Syndrome; Coronary Disease
Coagulation factor IX inhibitor
PEGNIVACOGIN
×
Maximum Phase:
3
First Approval:
None
UNII:
AYC3D1NPYB
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALICAFORSEN
3
Oligonucleotide
Investigational
Unknown
Unknown
Inflammatory Bowel Diseases; Colitis, Ulcerative; Crohn Disease; Pouchitis
Intercellular adhesion molecule-1 mRNA 3'UTR antisense inhibitor
ALICAFORSEN
×
Maximum Phase:
3
First Approval:
None
UNII:
J8435V445B
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TASISULAM SODIUM
3
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
TASISULAM SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
O3955SHR9J
Molecule Type:
Small molecule
Molecular Formula:
C11H5BrCl2NNaO3S2
Molecular Weight:
437.1
AlogP:
3.94
PSA:
63.24
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PUCOTENLIMAB
3
Antibody
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Thyroid Neoplasms; Urinary Bladder Neoplasms; Stomach Neoplasms
Programmed cell death protein 1 inhibitor
PUCOTENLIMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LECITHIN
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LECITHIN
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C10H20NO8P
Molecular Weight:
313.24
AlogP:
-1.09
PSA:
111.19
HBD:
0.0
HBA:
#RotB:
12.0
Source:
SEMUSTINE
3
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Glioblastoma; Graft vs Host Disease; Neoplasms
DNA cross-linking agent
SEMUSTINE
×
Maximum Phase:
3
First Approval:
None
UNII:
6YY7T1T567
Molecule Type:
Small molecule
Molecular Formula:
C10H18ClN3O2
Molecular Weight:
247.73
AlogP:
2.5
PSA:
61.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ESCHSCHOLTZIA CALIFORNICA
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ESCHSCHOLTZIA CALIFORNICA
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIRIKIZUMAB
3
Antibody
Investigational
Unknown
Unknown
Colitis, Ulcerative; Crohn Disease; Psoriasis
Interleukin-23 inhibitor
MIRIKIZUMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
Z7HVY03PHP
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AT-001
3
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Aldose reductase inhibitor
AT-001
×
Maximum Phase:
3
First Approval:
None
UNII:
E8I3O45DDU
Molecule Type:
Small molecule
Molecular Formula:
C17H10F3N5O3S
Molecular Weight:
421.36
AlogP:
2.49
PSA:
110.86
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SQUALAMINE LACTATE
3
Small molecule
Investigational
Unknown
Unknown
Diabetic Retinopathy; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Macular Degeneration
Sodium/hydrogen exchanger 3 inhibitor
SQUALAMINE LACTATE
×
Maximum Phase:
3
First Approval:
None
UNII:
4WE915J1KX
Molecule Type:
Small molecule
Molecular Formula:
C37H73N3O9S
Molecular Weight:
736.07
AlogP:
5.55
PSA:
133.91
HBD:
5.0
HBA:
#RotB:
16.0
Source:
MEDI-500
3
Antibody
Investigational
Unknown
Unknown
Unknown
T-cell receptor antagonist
MEDI-500
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VASOACTIVE INTESTINAL PEPTIDE
3
Protein
Investigational
Unknown
Unknown
Lymphoma, T-Cell, Peripheral
Unknown
VASOACTIVE INTESTINAL PEPTIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
6J2WVD66KR
Molecule Type:
Protein
Molecular Formula:
C147H237N43O43S
Molecular Weight:
3326.84
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PLASMALYTE A
3
Unknown
Investigational
Unknown
Unknown
Ischemia; Myocardial Infarction; Anterior Wall Myocardial Infarction; Respiratory Distress Syndrome; Wounds and Injuries
Unknown
PLASMALYTE A
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
I-131 IODOCHOLESTEROL
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
I-131 IODOCHOLESTEROL
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PENTETREOTIDE
3
Protein
Investigational
Unknown
Unknown
Neuroendocrine Tumors
Unknown
PENTETREOTIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
G083B71P98
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ADRABETADEX
3
Oligosaccharide
Investigational
Unknown
Unknown
Niemann-Pick Disease, Type C
Unknown
ADRABETADEX
×
Maximum Phase:
3
First Approval:
None
UNII:
8W6Q67R6NX
Molecule Type:
Oligosaccharide
Molecular Formula:
C54H94O38
Molecular Weight:
1351.31
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
IODOCHOLESTEROL
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IODOCHOLESTEROL
×
Maximum Phase:
3
First Approval:
None
UNII:
4A4E6EXB6U
Molecule Type:
Small molecule
Molecular Formula:
C27H45IO
Molecular Weight:
512.56
AlogP:
7.8
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
6.0
Source:
SURUFATINIB
3
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Liver Diseases; Biliary Tract Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Head and Neck Neoplasms; Nasopharyngeal Neoplasms; Neoplasms; Thyroid Neoplasms; Neuroendocrine Tumors
Fibroblast growth factor receptor 1 inhibitor
SURUFATINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
B2K5L1L8S9
Molecule Type:
Small molecule
Molecular Formula:
C24H28N6O3S
Molecular Weight:
480.59
AlogP:
3.78
PSA:
112.24
HBD:
3.0
HBA:
#RotB:
10.0
Source:
NERIDRONIC ACID
3
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis, Knee; Complex Regional Pain Syndromes
Unknown
NERIDRONIC ACID
×
Maximum Phase:
3
First Approval:
None
UNII:
8U27U3RIN4
Molecule Type:
Small molecule
Molecular Formula:
C6H17NO7P2
Molecular Weight:
277.15
AlogP:
-0.49
PSA:
161.31
HBD:
6.0
HBA:
#RotB:
7.0
Source:
XL550
3
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Essential Hypertension; Hyperaldosteronism; Hypertension
Mineralocorticoid receptor antagonist
XL550
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEVENOPRAN
3
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Constipation
Mu opioid receptor antagonist
BEVENOPRAN
×
Maximum Phase:
3
First Approval:
None
UNII:
IC58Q2EHPJ
Molecule Type:
Small molecule
Molecular Formula:
C20H26N4O4
Molecular Weight:
386.45
AlogP:
2.28
PSA:
108.59
HBD:
2.0
HBA:
#RotB:
9.0
Source:
1
2
…
207
208
209
210
211
212
213
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA